$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000008611516000309 Filed on October 28, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.900M	$4.700M	$4.000M
YoY Change	-2.5%	17.5%	-4.76%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$3.900M	$4.700M	$4.000M
YoY Change	0.0%	17.5%	-4.76%
Operating Profit	-$3.928M	-$4.687M	-$3.962M
YoY Change	-0.76%	18.3%	-5.15%
Interest Expense	-$17.80M	-$17.00M	-$8.400M
YoY Change	74.51%	102.38%	-12.5%
% of Operating Profit
Other Income/Expense, Net	$64.00K	-$2.405M	$704.0K
YoY Change	-176.19%	-441.62%	-386.18%
Pretax Income	-$21.70M	-$24.09M	-$11.63M
YoY Change	52.06%	107.13%	-16.98%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$21.70M	-$24.09M	-$11.63M
YoY Change	52.06%	107.13%	-16.98%
Net Earnings / Revenue
Basic Earnings Per Share	-$1.07	-$1.18	-$0.56
Diluted Earnings Per Share	-$1.07	-$1.18	-$0.56
COMMON SHARES
Basic Shares Outstanding	20.24M shares	20.39M shares	20.92M shares
Diluted Shares Outstanding		20.39M shares	20.92M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.40M	$66.30M	$93.50M
YoY Change	-52.43%	-29.09%	-38.45%
Cash & Equivalents	$22.06M	$52.50M	$63.71M
Short-Term Investments	$8.400M	$13.80M	$29.80M
Other Short-Term Assets	$2.100M	$1.900M	$2.000M
YoY Change	-63.79%	-5.0%	33.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$32.55M	$68.22M	$95.48M
YoY Change	-53.28%	-28.55%	-37.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.873M	$1.955M	$1.438M
YoY Change	-12.68%	35.95%	1413.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$154.7M	$151.9M	$144.9M
YoY Change	1.86%	4.79%	1.92%
Other Assets	$296.0K	$296.0K	$1.903M
YoY Change	-71.46%	-84.45%	-11.73%
Total Long-Term Assets	$199.3M	$185.5M	$179.7M
YoY Change	6.47%	3.25%	0.43%
TOTAL ASSETS
Total Short-Term Assets	$32.55M	$68.22M	$95.48M
Total Long-Term Assets	$199.3M	$185.5M	$179.7M
Total Assets	$231.8M	$253.7M	$275.2M
YoY Change	-9.74%	-7.78%	-17.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$140.0K	$110.0K	$253.0K
YoY Change	-51.72%	-56.52%	-3.07%
Accrued Expenses	$2.223M	$3.136M	$3.644M
YoY Change	-20.29%	-13.94%	9.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$5.861M	$6.505M	$7.034M
YoY Change	-8.66%	-7.52%	5.52%
LONG-TERM LIABILITIES
Long-Term Debt	$52.60M	$52.10M	$51.40M
YoY Change	1.74%	1.36%	2.19%
Other Long-Term Liabilities	$3.630M	$3.947M	$3.928M
YoY Change	-8.45%	0.48%	13.17%
Total Long-Term Liabilities	$3.630M	$3.947M	$3.928M
YoY Change	-8.45%	0.48%	13.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.861M	$6.505M	$7.034M
Total Long-Term Liabilities	$3.630M	$3.947M	$3.928M
Total Liabilities	$62.05M	$62.60M	$62.40M
YoY Change	1.16%	0.31%	3.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$626.9M	-$605.2M	-$590.0M
YoY Change	3.75%	2.58%	11.4%
Common Stock	$818.2M	$820.0M	$820.8M
YoY Change	-0.17%	-0.1%	-0.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$21.06M	$23.47M	$18.08M
YoY Change	7.62%	29.8%	-21.9%
Treasury Stock Shares	1.209M shares	1.335M shares	877.0K shares
Shareholders Equity	$169.8M	$191.1M	$212.8M
YoY Change
Total Liabilities & Shareholders Equity	$231.8M	$253.7M	$275.2M
YoY Change	-9.74%	-7.78%	-17.2%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	-$21.70M	-$24.09M	-$11.63M
YoY Change	52.06%	107.13%	-16.98%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$4.600M	-$3.300M	-$2.900M
YoY Change	27.78%	13.79%	7.41%
INVESTING ACTIVITIES
Capital Expenditures	-$300.0K	$0.00	-$200.0K
YoY Change	-80.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$19.20M	-$10.40M	$7.500M
YoY Change	-14.67%	-238.67%	-116.59%
Cash From Investing Activities	-$19.50M	-$10.40M	$7.400M
YoY Change	-18.75%	-240.54%	-116.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-100.0K	-1.600M
YoY Change	-100.0%	-93.75%
NET CHANGE
Cash From Operating Activities	-4.600M	-3.300M	-2.900M
Cash From Investing Activities	-19.50M	-10.40M	7.400M
Cash From Financing Activities	0.000	-100.0K	-1.600M
Net Change In Cash	-24.10M	-13.80M	2.900M
YoY Change	-21.75%	-575.86%	-106.07%
FREE CASH FLOW
Cash From Operating Activities	-$4.600M	-$3.300M	-$2.900M
Capital Expenditures	-$300.0K	$0.00	-$200.0K
Free Cash Flow	-$4.300M	-$3.300M	-$2.700M
YoY Change	104.76%	22.22%	0.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000086115
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20238359	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SAFEGUARD SCIENTIFICS INC
	dei	Trading Symbol TradingSymbol	SFE
CY2016Q3	sfe	Cash Liabilityfor Performance Based Units CashLiabilityforPerformanceBasedUnits	0	USD
CY2001Q4	sfe	Future Annual Payment To Chairman And Chief Executive Officer FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer	650000	USD
CY2015Q3	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	0	USD
CY2016Q3	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	3000	USD
	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	13000	USD
CY2016Q3	sfe	Partner Companies Not Consolidated In Financial Statements PartnerCompaniesNotConsolidatedInFinancialStatements	28	nonconsolidated_partner_company
CY2016Q3	sfe	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Award Vesting Types SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofAwardVestingTypes	2	vesting_type
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	290000	USD
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	110000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2789000	USD
CY2016Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3136000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-246000	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-233000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	817434000	USD
CY2016Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	817887000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1879000	USD
CY2015Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	12771000	USD
CY2016Q3	us-gaap	Advances To Affiliate AdvancesToAffiliate	18195000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	148000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1140000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	604000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1879000	USD
CY2015Q4	us-gaap	Assets Assets	256843000	USD
CY2016Q3	us-gaap	Assets Assets	253738000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	69668000	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	68218000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	111897000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63708000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32838000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52496000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-48189000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	19658000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2015Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	50956000	USD
CY2016Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	52145000	USD
CY2015Q4	us-gaap	Cost Method Investments CostMethodInvestments	6990000	USD
CY2016Q3	us-gaap	Cost Method Investments CostMethodInvestments	2861000	USD
CY2015Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2015Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	800000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.17
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.17
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3338000	USD
CY2016Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3259000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	182809000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	190168000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-105042000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-135045000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	291860000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	299768000	USD
CY2015Q4	us-gaap	Equity Method Investments EquityMethodInvestments	151840000	USD
CY2016Q3	us-gaap	Equity Method Investments EquityMethodInvestments	151885000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3962000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13596000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4687000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14764000	USD
CY2015Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	31020000	USD
CY2016Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	13816000	USD
CY2015Q4	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	9743000	USD
CY2016Q3	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	10328000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11628000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45253000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24085000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-561000	USD
CY2015Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-7635000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-30062000	USD
CY2016Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-16345000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	17954000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1133000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	3383000	USD
CY2016Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1161000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	3465000	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	398000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1487000	USD
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	513000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1460000	USD
CY2015Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	171601000	USD
CY2016Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	172941000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	28043000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	35386000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	61338000	USD
CY2016Q3	us-gaap	Liabilities Liabilities	62597000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	676000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	256843000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	253738000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6417000	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6505000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1072000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5821000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33031000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	39593000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14086000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14114000	USD
CY2015Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	2649000	USD
CY2016Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	0	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3962000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13596000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4687000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14764000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1037000	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	296000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-11628000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-45253000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-24082000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-548000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3965000	USD
CY2016Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3947000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	704000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	301000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2405000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1746000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	10935000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	17741000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1748000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5389000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	437000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	52181000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	34841000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	23875000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	18733000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	402000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	73000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5810000	USD
CY2016Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1906000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	1290000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	1741000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	25029000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	73854000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	-11628000	USD
	us-gaap	Profit Loss ProfitLoss	-45253000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	-24085000	USD
	us-gaap	Profit Loss ProfitLoss	-561000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2145000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1955000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-604270000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-605203000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	12000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-318000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5389000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	195505000	USD
CY2016Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	191141000	USD
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	993000	shares
CY2016Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	1335000	shares
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	19570000	USD
CY2016Q3	us-gaap	Treasury Stock Value TreasuryStockValue	23467000	USD
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20919000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20892000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20387000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20390000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20919000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20892000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20387000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20390000	shares

Files In Submission

Name	View Source	Status
0000086115-16-000309-index-headers.html	Edgar Link	pending
0000086115-16-000309-index.html	Edgar Link	pending
0000086115-16-000309.txt	Edgar Link	pending
0000086115-16-000309-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20160930.xml	Edgar Link	completed
sfe-20160930.xsd	Edgar Link	pending
sfe-20160930_cal.xml	Edgar Link	unprocessable
sfe-20160930_def.xml	Edgar Link	unprocessable
sfe-20160930_lab.xml	Edgar Link	unprocessable
sfe-20160930_pre.xml	Edgar Link	unprocessable
sfe-2016xq3.htm	Edgar Link	pending
sfe-2016xq3xex311.htm	Edgar Link	pending
sfe-2016xq3xex312.htm	Edgar Link	pending
sfe-2016xq3xex321.htm	Edgar Link	pending
sfe-2016xq3xex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2016 Q4 Form 10-Q Financial Statement

#000008611516000309 Filed on October 28, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2016 Q4 Form 10-Q Financial Statement

#000008611516000309 Filed on October 28, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes